Proprietary Synthetic Gene Circuit Platform: Senti Biosciences has developed a unique and sophisticated synthetic biology platform that leverages gene circuits to precisely program the behavior of therapeutic cells, offering unprecedented control over their activity in vivo.

Modular and Programmable Design: Their gene circuit technology is highly modular, enabling the creation of customizable and programmable cell and gene therapies that can sense multiple biological inputs and execute specific therapeutic outputs, aiming for enhanced specificity and safety.

Extensive Intellectual Property Portfolio: The company holds a growing portfolio of patents and proprietary know-how covering its gene circuit designs, manufacturing processes, and therapeutic applications, establishing a strong defensible position in programmable medicines.